DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Fuchs CS, Moore MR, Harker G. et al.
Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.
J Clin Oncol 2003;
21: 807-814
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.